MedTrace Logo

A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

NCT01644435 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-10-15

No results posted yet for this study

Summary

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment, Physicians assessment score and Patients self assessment score.

Conditions

  • ACNE SCARRING

Interventions

BIOLOGICAL

Autologous Human Platelet Lysate

Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring

BIOLOGICAL

Autologous Human Platelet Lysate

Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring

Sponsors & Collaborators

  • Kasiak Research Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Sharmila Patil, Dr. · Dermocosmetic laser center hair and skin clinic

  • Pankaj Maniar, Dr. · Radiance Cosmetology Clinique

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644435 on ClinicalTrials.gov